WASHINGTON, D.C. — The U.S. Food and Drug Administration has launched a pilot program aimed at dramatically speeding up the back-and-forth communications between drug developers and federal regulators ...
Eli Lilly and Nvidia are partnering to build what the companies call the pharmaceutical industry's "most powerful" supercomputer and so-called AI factory to help accelerate drug discovery and ...
New approach methodologies (NAMs) aim to address the limitations of animal models by assessing drug efficacy and safety in a more ethical, human-relevant way. The term ‘NAMs’ encompasses several ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results